These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 22176478)

  • 41. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?
    Burgmann T; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 May; 99(5):889-93. PubMed ID: 15128356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
    Kong SC; Hurlstone DP; Pocock CY; Walkington LA; Farquharson NR; Bramble MG; McAlindon ME; Sanders DS
    J Clin Gastroenterol; 2005 Feb; 39(2):138-41. PubMed ID: 15681910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complementary and alternative medicine use among health plan members. A cross-sectional survey.
    Gray CM; Tan AW; Pronk NP; O'Connor PJ
    Eff Clin Pract; 2002; 5(1):17-22. PubMed ID: 11878283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN BRAZILIAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE.
    Henriques DP; Oliveira RR; Vanni J; Lima HP; Otiti JV; Neves FRM; Hammerle MB; Sassaki LY; Zaltman C
    Arq Gastroenterol; 2022; 59(3):375-382. PubMed ID: 36102435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey.
    Hilsden RJ; Meddings JB; Verhoef MJ
    Can J Gastroenterol; 1999 May; 13(4):327-32. PubMed ID: 10360993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complementary Medicine Use, Symptom Burden and Non-Adherence in Kidney Transplant Recipients.
    Markell MS; Terebelo S
    Explore (NY); 2018 Nov; 14(6):414-419. PubMed ID: 30337196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.
    Lindberg A; Fossum B; Karlen P; Oxelmark L
    BMC Complement Altern Med; 2014 Oct; 14():407. PubMed ID: 25338541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: a Canadian national survey.
    Li FX; Verhoef MJ; Best A; Otley A; Hilsden RJ
    Can J Gastroenterol; 2005 Sep; 19(9):567-73. PubMed ID: 16151549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse clinical phenotype in inflammatory bowel disease: a cross sectional study identifying factors potentially amenable to change.
    van Langenberg DR; Lange K; Hetzel DJ; Holtmann GJ; Andrews JM
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1250-8. PubMed ID: 20594252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dietary modifications, nutritional supplements and alternative medicine in paediatric patients with inflammatory bowel disease.
    Gerasimidis K; McGrogan P; Hassan K; Edwards CA
    Aliment Pharmacol Ther; 2008 Jan; 27(2):155-65. PubMed ID: 17944995
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer.
    Pedersen CG; Christensen S; Jensen AB; Zachariae R
    Eur J Cancer; 2009 Dec; 45(18):3172-81. PubMed ID: 19811905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study.
    Helyer LK; Chin S; Chui BK; Fitzgerald B; Verma S; Rakovitch E; Dranitsaris G; Clemons M
    BMC Cancer; 2006 Feb; 6():39. PubMed ID: 16504038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health status and health care utilisation of patients in complementary and conventional primary care in Switzerland--an observational study.
    Busato A; Dönges A; Herren S; Widmer M; Marian F
    Fam Pract; 2006 Feb; 23(1):116-24. PubMed ID: 16115833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and correlates of selected alternative and complementary medicine in adult renal transplant patients.
    Hess S; De Geest S; Halter K; Dickenmann M; Denhaerynck K
    Clin Transplant; 2009; 23(1):56-62. PubMed ID: 18786136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identifying predictors of low adherence in patients with inflammatory bowel disease.
    Coenen S; Weyts E; Ballet V; Noman M; Van Assche G; Vermeire S; Van Emelen J; Ferrante M
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):503-7. PubMed ID: 26760588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center.
    Ceballos C; Bao R; Dunkin D; Song Y; Li XM; Benkov K
    Gastroenterol Nurs; 2014; 37(4):265-71. PubMed ID: 25078040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease.
    Rawsthorne P; Shanahan F; Cronin NC; Anton PA; Löfberg R; Bohman L; Bernstein CN
    Am J Gastroenterol; 1999 May; 94(5):1298-303. PubMed ID: 10235210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there any association between impaired health-related quality of life and non-adherence to medical therapy in inflammatory bowel disease?
    Horváth G; Farkas K; Hollósi R; Nagy F; Szepes Z; Papp M; Palatka K; Miheller P; Lakatos L; Szamosi T; Nyári T; Wittmann T; Molnár T
    Scand J Gastroenterol; 2012 Nov; 47(11):1298-303. PubMed ID: 22935014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.
    Bensoussan M; Jovenin N; Garcia B; Vandromme L; Jolly D; Bouché O; Thiéfin G; Cadiot G
    Gastroenterol Clin Biol; 2006 Jan; 30(1):14-23. PubMed ID: 16514377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease].
    García-Planella E; Marín L; Domènech E; Bernal I; Mañosa M; Zabana Y; Gassull MA
    Med Clin (Barc); 2007 Jan; 128(2):45-8. PubMed ID: 17266900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.